Live
- Flawless Execution: Driver Tenure Solution Achieves Two Years of Zero Production Incidents
- TGBIE extends scholarship deadline to Nov 30
- Leading Data Analytics Expert Boosts Financial Services with Advanced Reports and Dashboards for Hedging and Asset Allocation
- 26 Young India Integrated Resi Schools to come up in State
- BGT 2024-25: Bumrah picks five as India take 46-run lead after bowling out Australia for 104
- Thrilling experience: KV students extract DNA from bananas
- BSP to hold maha dharna on Dec 1
- Telangana Jagruthi to submit report to BC Commission
- John Abraham opens up about his new business venture at Indian Racing Festival
- Sri Chaitanya students take out rally
Dr Reddy's launches insomnia treatment tablets
Dr Reddy's Laboratories on Tuesday said it has launched generic Ramelteon tablets used for treatment of insomnia in the US market.
Hyderabad: Dr Reddy's Laboratories on Tuesday said it has launched generic Ramelteon tablets used for treatment of insomnia in the US market.
The company has launched Ramelteon tablets in the strength of 8 mg after getting approval by the United States Food and Drug Administration (USFDA), Dr Reddy's said.
The product is a generic version of Takeda Pharmaceutical Company's Rozerem tablets in the same strength, it added.
The Rozerem brand had the US sales of around $91.3 million MAT (moving annual total) for the most recent 12 months ending in May 2019, the drug major said.
The company's generic 8 mg Ramelteon tablets are available in bottle count sizes of 30, 100 and 1,000, it added.
The tablets are indicated for the treatment of insomnia characterised by difficulty with sleep onset.
